Dr. Despina Siolas, MD, PhD(@DrDespina123) 's Twitter Profileg
Dr. Despina Siolas, MD, PhD

@DrDespina123

Medical Oncologist with specialty in gastrointestinal cancers. Research Focus is Pancreatic Cancer and Colon Cancer. Assistant Professor @weillcornell

ID:2818171151

linkhttps://weillcornell.org/despina-siolas-md-phd calendar_today09-10-2014 03:02:15

1,4K Tweets

465 Followers

228 Following

Bhavana Pothuri(@BPothuri) 's Twitter Profile Photo

Turn your frown upside down- come learn about EQ with ⁦Hilary Hinckle⁩ and me at on Friday 3/15/24 PM! Limited spots left! Be better leaders and communicators in ! ⁦SGO⁩ ⁦The GOG Foundation Inc.⁩ ⁦IGCS⁩ ⁦⁦⁦ASCO

Turn your frown upside down- come learn about EQ with ⁦@HilaryHinckle⁩ and me at #SGO2024 on Friday 3/15/24 PM! Limited spots left! Be better leaders and communicators in #PowerofSharedPurpose! ⁦@SGO_org⁩ ⁦@GOG⁩ ⁦@IGCSociety⁩ ⁦⁦⁦@ASCO⁩
account_circle
NEJM(@NEJM) 's Twitter Profile Photo

This editorial describes the science behind a study of a noninvasive blood-based assay of cell-free DNA to screen for colorectal cancer in an average-risk population. Read the full editorial: nej.md/43noybx

This editorial describes the science behind a study of a noninvasive blood-based assay of cell-free DNA to screen for colorectal cancer in an average-risk population. Read the full editorial: nej.md/43noybx
account_circle
NEJM(@NEJM) 's Twitter Profile Photo

Cholestasis: An impairment in bile secretion or flow caused by intrahepatic or extrahepatic disease. nej.md/3SYwVW8

Cholestasis: An impairment in bile secretion or flow caused by intrahepatic or extrahepatic disease. nej.md/3SYwVW8
account_circle
Cholangiocarcinoma Foundation(@curecc) 's Twitter Profile Photo

CCF supports , which takes place on the last day of Cholangiocarcinoma Awareness Month!

There are so many positive ongoing developments in the field of cholangiocarcinoma. Whether you are a patient or know a patient, there is more reason than ever to have hope.

CCF supports #RareDiseaseDay, which takes place on the last day of Cholangiocarcinoma Awareness Month! There are so many positive ongoing developments in the field of cholangiocarcinoma. Whether you are a patient or know a patient, there is more reason than ever to have hope.
account_circle
Dr. Bishoy M. Faltas(@FaltasLab) 's Twitter Profile Photo

Grateful for our new funding from the Irma T. Hirschl and Monique Weill-Caulier Research Award which will support our research for the next 5 years.

account_circle
Ashish Saxena, MD, PhD(@DrAshish_Saxena) 's Twitter Profile Photo

Kudos to Dr. Christine Garcia who stole the show at the American College of Surgeons (ACS) Cancer Conference in Austin, Tx!
Christine reviewed her QI initiatives at NYPH-WCMC during a panel on “Improving Quality in Cancer Programs: Best Practice Examples”

Kudos to Dr. Christine Garcia who stole the show at the American College of Surgeons (ACS) Cancer Conference in Austin, Tx! Christine reviewed her QI initiatives at NYPH-WCMC during a panel on “Improving Quality in Cancer Programs: Best Practice Examples”
account_circle
nature(@Nature) 's Twitter Profile Photo

A journal reviewer accused Lizzie Wolkovich of using ChatGPT to write a manuscript. She hadn’t — but her paper was rejected anyway go.nature.com/48pFU8q

account_circle
WCM GI Cancer(@WCMGIcancer) 's Twitter Profile Photo

From The ASCO Post: results from long-term follow-up of a led by Dr. Manish Shah (@mdmanishshah) show the benefit of adding pembrolizumab to chemotherapy for advanced bit.ly/3vYBdVN

account_circle
Kirsten Bibbins-Domingo(@KBibbinsDomingo) 's Twitter Profile Photo

This Viewpoint

AI-Generated Clinical Summaries Require More Than Accuracy jamanetwork.com/journals/jama/…

PaulYiMD Dan Morgan

…is a Top Viewed article at JAMA this week

This Viewpoint AI-Generated Clinical Summaries Require More Than Accuracy jamanetwork.com/journals/jama/… @PaulYiMD @dr_dmorgan …is a Top Viewed article at JAMA this week
account_circle
WCM GI Cancer(@WCMGIcancer) 's Twitter Profile Photo

“Neoadjuvant botensilimab/balstilimab is a safe and active regimen in both pMMR/MSS and dMMR/MSI-H CRC,” said Dr. Pashtoon Kasi MD, MS re: he shared ASCO evaluating a new potential treatment regimen for bit.ly/4bhVnKp (cc: Targeted Oncology)

account_circle